Anticancer activity of osmium(VI) nitrido complexes in patient-derived glioblastoma initiating cells and in vivo mouse models

This publication has 54 references indexed in Scilit:

• Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3
  Proceedings of the National Academy of Sciences, 2013
• Metal–Arene Complexes with Indolo[3,2-c]-quinolines: Effects of Ruthenium vs Osmium and Modifications of the Lactam Unit on Intermolecular Interactions, Anticancer Activity, Cell Cycle, and Cellular Accumulation
  Organometallics, 2013
• Osmium(IV) complexes with 1H- and 2H-indazoles: Tautomer identity versus spectroscopic properties and antiproliferative activity
  Journal of Inorganic Biochemistry, 2012
• Indirubins Decrease Glioma Invasion by Blocking Migratory Phenotypes in Both the Tumor and Stromal Endothelial Cell Compartments
  Cancer Research, 2011
• In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model
  Journal of Inorganic Biochemistry, 2010
• Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs
  Drug Discovery Today, 2009
• Platinum neurotoxicity pharmacogenetics
  Molecular Cancer Therapeutics, 2009
• The resurgence of platinum-based cancer chemotherapy
  Nature Reviews Cancer, 2007
• Cisplatin: mode of cytotoxic action and molecular basis of resistance
  Oncogene, 2003
• Reversible interconversion between a nitrido complex of osmium(VI) and an ammine complex of osmium(II)
  Journal of the American Chemical Society, 1990